Table 1 Clinical data after primary Cytomegalovirus infection in this subject
From: Primary Epstein–Barr virus infection shortly after primary Cytomegalovirus infection: a case report
Variable | Result | Reference range | Variable | Result | Reference range |
|---|---|---|---|---|---|
Peripheral blood | Blood biochemistry | ||||
White blood cells (/μL) | 1710 | 3300–8600 | Total protein (g/dL) | 6.3 | 6.6–8.1 |
Neutrophils (%) | 76.0 | 52.0–80.0 | Albumin (g/dL) | 3.6 | 4.1–5.1 |
Eosinophils (%) | 0.0 | 1.0–5.0 | Globulin (g/dL) | 2.7 | 2.2–3.4 |
Basophils (%) | 0.0 | 0.0–1.0 | Cholinesterase (U/L) | 163 | 240–486 |
Monocytes (%) | 5.0 | 1.0–6.0 | Total bilirubin (mg/dL) | 2.7 | 0.4–1.5 |
Lymphocytes (%) | 18.0 | 20.0–40.0 | Direct bilirubin (%) | 11 | 30–52 |
Atypical lymphocytes (%) | 1.0 | AST (U/L) | 30 | 13–30 | |
Red blood cells (×104/μL) | 429 | 435–555 | ALT (U/L) | 28 | 10–42 |
Hemoglobin (g/dL) | 12.8 | 13.7–16.8 | LDH (U/L) | 221 | 124–222 |
Platelets (×104/μL) | 8.7 | 15.8–34.8 | ALP (U/L) | 276 | 106–322 |
Congealing fibrinogenolysis system | γ-GTP (U/L) | 78 | 13–64 | ||
PT (seconds) | 14.3 | 9.3–12.5 | BUN (mg/dL) | 8 | 8–20 |
PT-INR | 1.25 | 0.85–1.13 | Creatinine (mg/dL) | 0.69 | 0.65–1.07 |
PT activity (%) | 66.5 | 80.7–125.2 | Uric acid (mg/dL) | 5.2 | 2.6–5.5 |
APTT (seconds) | 46.7 | 26.9–38.1 | Amylase (U/L) | 89 | 44–132 |
Fibrinogen (mg/dL) | 263 | 160–380 | Creatinine kinase (U/L) | 62 | 41–153 |
Urinary test | Plasma glucose (mg/dL) | 91 | |||
Urinary pH | 7.0 | 5.0–7.5 | Total cholesterol (mg/dL) | 168 | 142–248 |
Urinary protein | ± | − | LDL cholesterol (mg/dL) | 89 | 65–139 |
Urinary sugar | − | − | HDL cholesterol (mg/dL) | 57 | 40–90 |
Urinary ketone body | − | − | Triglyceride (mg/dL) | 71 | 40–149 |
Urinary blood | ± | − | Sodium (mmol/L) | 135 | 138–145 |
Urinary bacteria | ± | − | Potassium (mmol/L) | 3.7 | 3.6–4.8 |
Chloride (mmol/L) | 102 | 101–108 | |||
CRP (mg/dL) | 3.92 | < 0.14 | |||
Procalcitonin (ng/mL) | 0.39 | 0.00–0.05 | |||